Epstein-Barr Virus (EBV) Prevalence and the Risk of Reactivation in Patients with Inflammatory Arthritis Using Anti-TNF Agents and in those who are Biologic Naive [0.03%]
使用抗肿瘤坏死因子药物和生物制剂初治的炎性关节炎患者中的爱泼斯坦-巴尔病毒(EBV)感染率及再激活风险
Emily McKeown,Janet E Pope,Suzanne Leaf
Emily McKeown
Objective: Anti-TNF agents (etanercept, infliximab and adalimumab) are widely used in inflammatory conditions, such as rheumatoid arthritis; however, they are not without side effects, potentially including lymphoma. We c...
Efficacy of acupuncture for the treatment of fibromyalgia: systematic review and meta-analysis of randomized trials [0.03%]
针刺治疗纤维肌痛症疗效的系统评价和meta分析
Eva Martin-Sanchez,Eva Torralba,Elena Díaz-Domínguez et al.
Eva Martin-Sanchez et al.
Objective: The study sought to ascertain the effectiveness of acupuncture as a treatment for fibromyalgia Materials and methods: THE FO...
The Nature of Increased Circulating CD4CD25Foxp3 T Cells in Patients with Systemic Lupus Erythematosus: A Novel Hypothesis [0.03%]
系统性红斑狼疮患者循环中CD4CD25Foxp3 T细胞增多的属性：一种新的假说
Bing Yan,Yi Liu
Bing Yan
The forkhead family transcriptional factor (Foxp3) is an important lineage marker for regulatory T (Treg) cells. Foxp3 expression is primarily restricted to CD4+CD25+ cell population. Recently, an intriguing phenomenon is highlighted that t...
Discrepancy among observational studies: example of naproxen-associated adverse events [0.03%]
观察研究间的分歧：萘普生相关不良反应为例
Elham Rahme,Jean-Philippe Lafrance,Hacene Nedjar et al.
Elham Rahme et al.
Background: Observational studies assessing the cardiovascular adverse effect of naproxen have had conflicting results. It is not clear whether variation in population characteristics between studies may explain some of t...
Sustained Remission After Combination Therapy with Rituximab and Etanercept in Two Patients with Rheumatoid Arthritis After TNF Failure: Case Report [0.03%]
两例肿瘤坏死因子抑制剂治疗失败的类风湿关节炎患者接受利妥昔单抗联合依那西普治疗后持续缓解：病例报告
Martin Feuchtenberger,Christian Kneitz,Petra Roll et al.
Martin Feuchtenberger et al.
Objectives: Approximately up to 40% of patients with rheumatoid arthritis (RA) fail to respond to tumor necrosis factor (TNF) inhibitors, lose response over time or are unable to tolerate treatment. ...
Sequential Combination Therapy Leading to Sustained Remission in a Patient with SAPHO Syndrome [0.03%]
序贯联合治疗诱导克罗恩病患者的持续缓解
C E Huber,A G Judex,J Freyschmidt et al.
C E Huber et al.
The SAPHO syndrome represents a variety of clinically similar disorders with the key features of hyperostotic bone lesions in combination with chronic pustular skin disease. The respective pathophysiology of bone and joint manifestations in...
ANCA-Positive Patients: The Influence of PR3 and MPO Antibodies on Survival Rate and The Association with Clinical and Laboratory Characteristics [0.03%]
PR3和MPO抗体对ANCA阳性患者生存率的影响及其与临床和实验室特征的相关性
J C Drooger,A Dees,A J G Swaak
J C Drooger
Objectives: To compare the survival rate, and the clinical and laboratory characteristics in patients, characterized by the presence of certain anti-neutrophil cytoplasmic auto-antibodies (ANCAs). ...
Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: Results from a case control study and literature review [0.03%]
系统性红斑狼疮患者的妊娠预后正在改善——来自病例对照研究和文献回顾的结论
Sai Yan Yuen,Adriana Krizova,Janine M Ouimet et al.
Sai Yan Yuen et al.
Objectives: For women who suffer from systemic lupus erythematosus (SLE), pregnancy can be a concern, placing the mother and fetus at risk. Our objectives were to assess the risk of adverse pregnancy outcome, disease flar...
Factor structure of the arthritis body experience scale (ABES) in a U.S. population of people with osteoarthritis (OA), rheumatoid arthritis (RA), fibromyalgia (FM) and other rheumatic conditions [0.03%]
美国骨关节炎、类风湿性关节炎、纤维肌痛及其他风湿性疾病患者的关节炎身体体验量表（ABES）的因素结构
J E A Boyington,R Devellis,J Shreffler et al.
J E A Boyington et al.
Objective: To examine the psychometric properties of the Arthritis Body Experience Scale (ABES) in a US sample of people with osteoarthritis, rheumatoid arthritis, fibromyalgia and other rheumatic conditions. ...
Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis [0.03%]
利妥昔单抗短暂消耗B细胞不影响类风湿关节炎患者体内调节性T细胞的频率
Martin Feuchtenberger,Sabine Müller,Petra Roll et al.
Martin Feuchtenberger et al.
Objectives: Transient B cell depletion with the monoclonal anti-CD20 antibody rituximab has shown favourable clinical responses in patients with rheumatoid arthritis (RA). Recently a characteristic regeneration pattern of...